Australia, Dec. 10 -- Amgen Inc., owns the trademark (2446654) for 'CONFIPEN' till April 30, 2034.
Status: registered:
Registered/protected
Classes: 5 [Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer and immune diseases and conditions.] and 10 [Injectors for medical purposes, namely, medical fluid injectors.]
Type of Mark: Word
Date of Acceptance: June 21
Registration Advertised: Dec. 9
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2446654.
Disclaimer: Curated by HT Syndication.
